Kaplan Fox & Kilsheimer LLP Encourages ZoomInfo Technologies Inc. (NASDAQ: GTM) Investors to Contact the Firm Before August 24, 2026

ZoomInfo’s Q1 2026 results led to a guidance cut, reducing 2026 revenue outlook to $1.185–$1.205B from $1.247–$1.267B. The company attributed a pause in purchasing decisions to “AI and agentic confusion,” while also announcing $45M–$60M of restructuring costs and layoffs of ~20% of staff. Shares dropped nearly 33% on May 12, closing at $4.06, and the article adds that a class action was filed alleging misleading investor disclosures around revenue guidance and demand for AI products.

Analysis

This is less about the lawsuit and more about the market re-rating a business whose growth engine appears to be losing pricing power. When a point solution starts seeing customers pause because they can build similar workflows with internal AI, the hit is usually not a one-quarter miss; it shows up as lower renewal quality, weaker upsell attach, and a longer sales cycle across the entire cohort of B2B software buyers. That tends to compress both the forward revenue multiple and the terminal growth assumption, which is why the equity can keep bleeding even after the initial gap down.

Competitive spillover likely favors broader suites and embedded workflow vendors over standalone sales-intelligence tools. Salesforce, HubSpot, and Microsoft are better positioned to absorb budget because they can bundle data, automation, and AI into larger procurement decisions, while smaller martech/sales-tech names may see the same “pause in purchasing” dynamic if buyers reassess whether they need separate tools. The contrarian risk is that litigation itself is mostly a sideshow: settlements here are usually manageable, so the real trade is on whether the demand softness is cyclical or a structural substitution event. Near term, the next catalyst is the subsequent earnings print and any channel checks on seat-based demand; 6-18 months out, the key question is whether GTM can re-accelerate net retention without heavy discounting.

Key Decisions for Investors

• Short GTM on any relief rally over the next 1-3 weeks; this is a fundamentals-not-litigation short, with the thesis invalidated if the next update shows stabilization in bookings/NRR or management re-raises FY26 guidance.
• Pair trade: short GTM / long CRM for 1-3 months to isolate the risk of point-solution substitution into broader platform consolidation; cover if software multiples de-rate broadly rather than just GTM-specific.
• Use GTM put spreads rather than naked puts if borrow/IV is elevated; target the next earnings window as the catalyst, with upside limited to a legal headline fade and downside tied to another guidance cut.
• Watch-for-alert: if GTM loses another 10-15% without a corresponding downgrade cycle in sell-side estimates, the move may be overdone and suitable for a tactical squeeze trade back to pre-gap levels.
• Avoid chasing the class-action headline as a standalone trade; the better tell is whether adjacent B2B software names with AI-heavy messaging start seeing slower pipeline conversion in the next quarter.